Presence of precore and core promoter mutants limits the probability of response to peginterferon in hepatitis B e antigen-positive chronic hepatitis B.
about
Metabonomic window into hepatitis B virus-related hepatic diseasesThe L60V Variation in Hepatitis B Virus Core Protein Elicits New Epitope-Specific Cytotoxic T Lymphocytes and Enhances Viral ReplicationAsian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update.Chronic hepatitis B: Advances in treatment.Mutations in pre-core and basal-core promoter regions of hepatitis B virus in chronic HBV patients from Golestan, Iran.Control of hepatitis B virus replication by interferons and Toll-like receptor signaling pathwaysPractical approach in hepatitis B e antigen-negative individuals to identify treatment candidates.Strategies to eliminate HBV infection.New point mutations in surface and core genes of hepatitis B virus associated with acute on chronic liver failure identified by complete genomic sequencing.Hepatitis B virus genotypes and variants.Precore/basal core promoter mutants quantification throughout phases of hepatitis B virus infection by SimpleprobeA cross-talk between Hepatitis B virus and host mRNAs confers viral adaptation to liverClose monitoring of hepatitis B surface antigen levels helps classify flares during peginterferon therapy and predicts treatment response.Mutation Changes in the preC/Core Promoter in HBeAg-Positive Patients With Chronic Hepatitis B During Interferon Therapy.PegIFN-α2a for the treatment of chronic hepatitis B and C: a 10-year history.Peginterferon α in the treatment of chronic hepatitis B.Progressive accumulation of mutations in the hepatitis B virus genome and its impact on time to diagnosis of hepatocellular carcinoma.Serum hepatitis B core-related antigen as a treatment predictor of pegylated interferon in patients with HBeAg-positive chronic hepatitis B.Patients with interferon-induced HBeAg seroconversion have a higher risk of HBV reactivation and HBeAg seroreversion.HBsAg plasma level kinetics: a new role for an old marker as a therapy response predictor in vertically infected children on combination therapy.Polymorphisms of HLA-DP are associated with response to peginterferon in Caucasian patients with chronic hepatitis B.The role of HBsAg levels in the current management of chronic HBV infection.Response-guided peginterferon therapy in hepatitis B e antigen-positive chronic hepatitis B using serum hepatitis B surface antigen levels.
P2860
Q26771253-573D8A6E-42C7-4634-BFB2-B7A07EF630BFQ27678163-BE66B732-2A1F-49B6-9FFE-EC6C626074B5Q30391932-E4B5F3B6-5F2C-4630-9F20-3D81CD365B5CQ33660010-B6D5F858-BAD5-4609-B7BD-9A2031BCBEC1Q33802585-203E9DD1-78B4-4DD9-A950-97B312B99B63Q34137297-DD2BF5D9-F608-47EF-8F74-AE95F6FEAC1EQ34168465-84F1AD2F-4605-4F8C-B070-FCA452CBF376Q34308129-30A79793-C68F-4511-9918-F3E0FDE0FA20Q35303894-CE7F1FF7-4873-4A55-A257-2A5027F59297Q35663838-071B3FAD-E3C0-452D-BF79-7B0F5B9F3CA3Q35692307-2DC0E462-01C8-40D5-B65F-EAD0B610B329Q35860325-5416A8BF-1D87-41B0-B66C-F7A616B2D7C4Q36457659-22D960E2-0C23-40F9-8B70-9CD1D840EE4FQ36566914-10AEE63B-202E-44DF-A5C9-7BE70A052AA5Q38102776-10164793-D59A-4A01-9975-D1D459F84E63Q38205028-E1616DED-C8E1-4B04-AA09-AD6E21F159B9Q39733935-B38CA6E3-1133-415D-9F02-AC4F53AD4C36Q41042019-75E79756-057D-471E-9BAB-3973864635E1Q41556990-778ACE7A-B12F-4377-9B0D-B6B3FF12A9B1Q41718138-C1A2C510-B05E-4187-8927-55DCC0D13E06Q42200827-BBE2A1E5-BA1A-4C5C-8886-6434AC983A30Q42360905-CE1AD8F5-F067-4366-8806-F0075A1B7D77Q44408807-F9B20616-A5CB-4594-A46E-E30FEE5CA9FE
P2860
Presence of precore and core promoter mutants limits the probability of response to peginterferon in hepatitis B e antigen-positive chronic hepatitis B.
description
2012 nî lūn-bûn
@nan
2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Presence of precore and core p ...... -positive chronic hepatitis B.
@ast
Presence of precore and core p ...... -positive chronic hepatitis B.
@en
Presence of precore and core p ...... -positive chronic hepatitis B.
@nl
type
label
Presence of precore and core p ...... -positive chronic hepatitis B.
@ast
Presence of precore and core p ...... -positive chronic hepatitis B.
@en
Presence of precore and core p ...... -positive chronic hepatitis B.
@nl
prefLabel
Presence of precore and core p ...... -positive chronic hepatitis B.
@ast
Presence of precore and core p ...... -positive chronic hepatitis B.
@en
Presence of precore and core p ...... -positive chronic hepatitis B.
@nl
P2093
P2860
P50
P356
P1433
P1476
Presence of precore and core p ...... -positive chronic hepatitis B.
@en
P2093
E Jenny Heathcote
Hakan Senturk
Harry L A Janssen
Milan J Sonneveld
Suzan D Pas
Vincent Rijckborst
P2860
P356
10.1002/HEP.25636
P407
P577
2012-04-25T00:00:00Z